LEX-WK-78D009THcrawled 2026-08-03 23:24Z
What does the GKV-BStabG Reform Change for Pharma Pricing & Reimbursement in Germany? And the Reforms Are Not Over: What to Expect From the New German Minister of Health and the Pharma Dialogue?
Dr. Dr. Adem Koyuncu · Maximilian Aretz · Global Policy Watch · Published August 3, 2026
Work details
- author
- Dr. Dr. Adem Koyuncu · Maximilian Aretz
- firm or organization
- Covington & Burling LLP
- publication
- Global Policy Watch
- practice area
- Business and Commercial · Health Care and Life Sciences
- published
- 2026-08-03
Citation
Dr. Dr. Adem Koyuncu, Maximilian Aretz, What does the GKV-BStabG Reform Change for Pharma Pricing & Reimbursement in Germany? And the Reforms Are Not Over: What to Expect From the New German Minister of Health and the Pharma Dialogue?, Global Policy Watch (August 3, 2026) [The Library at LexBlog, LEX-WK-78D009TH, lexpid.org/78D009TH]